Kardigan, Inc.
NASDAQ:KARDBiotechnology
Healthcare
$12.32 +3.50%
+$0.77 today
- Market cap
- $1.10B
- Beta
- 0.00
52W Low $16.25High $24.00
Volume 0.55M
Average 5.84M
KARD Other Financing Activities
Financing cash flows not reported separately.
No reported Other Financing Activities figures are available to summarize.
Other Financing Activities history
Currency unavailable · from the cash flow
No Other Financing Activities data reported for this period type.
Other Financing Activities vs competitors
How KARD compares with its peers on the latest reported figures
KARD Competitors
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $79.48M USD | -208.4% | — | 112.0% | |
| FY2025 | $42.57M USD | — | — | 228.7% | |
| LTM Mar 2026 | $415K USD | — | — | 184.4% | |
| LTM Mar 2026 | $31.62K USD | +3.3% | — | — | |
| LTM Jun 2026 | $0 USD | -100.0% | — | 0.0% | |
| — | — | — | — | — | |
| Peer median (excluding KARD) | — | -100.0% | — | 148.2% | |
Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Currency unavailable
Kardigan, Inc.
NASDAQ:KARD
Intrinsic Alpha fair value
Locked
Current Price
$12.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.